Using ChIP-chip methods we have identified a novel pattern of high frequency co-localization of the MYCN transcription factor and the MeCP2 methyl binding protein to genomic sites in neuroblastoma Kelly cells. The gene discussed is MECP2; the disease is neuroblastoma.